Ruiz-Del-Yerro, E., Garcia-Jimenez, I., Mamchaoui, K., Arechavala-Gomeza, V. :
Myoblots: dystrophin quantification by in-cell western assay for a streamlined development of DMD treatments
Neuropathol Appl Neurobiol, 2017 ; (SP) :
Publications (1181)
Stantzou, A., Schirwis, E., Swist, S., Alonso-Martin, S., Polydorou, I., Zarrouki, F., Mouisel, E., Beley, C., Julien, A., Le Grand, F., Garcia, L., Colnot, C., Birchmeier, C., Braun, T., Schuelke, M., Relaix, F., Amthor, H. :
BMP signaling regulates satellite cell-dependent postnatal muscle growth Development, 2017 ; 144 (15) : 2737-2747
BMP signaling regulates satellite cell-dependent postnatal muscle growth Development, 2017 ; 144 (15) : 2737-2747
Monge, C., DiStasio, N., Rossi, T., Sebastien, M., Sakai, H., Kalman, B., Boudou, T., Tajbakhsh, S., Marty, I., Bigot, A., Mouly, V., Picart, C. :
Quiescence of human muscle stem cells is favored by culture on natural biopolymeric films Stem Cell Res Ther, 2017 ; 8 (1) : 104
Quiescence of human muscle stem cells is favored by culture on natural biopolymeric films Stem Cell Res Ther, 2017 ; 8 (1) : 104
Arandel, L., Polay-Espinosa, M., Matloka, M., Bazinet, A., De Dea Diniz, D., Naouar, N., Rau, F., Jollet, A., Edom-Vovard, F., Mamchaoui, K., Tarnopolsky, M., Puymirat, J., Battail, C., Boland, A., Deleuze, J. F., Mouly, V., Klein, A. F., Furling, D. :
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds Dis Model Mech, 2017 ; 10 (4) : 487-497
Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds Dis Model Mech, 2017 ; 10 (4) : 487-497
Wahbi, K., Babuty, D., Probst, V., Wissocque, L., Labombarda, F., Porcher, R., Becane, H. M., Lazarus, A., Behin, A., Laforet, P., Stojkovic, T., Clementy, N., Dussauge, A. P., Gourraud, J. B., Pereon, Y., Lacour, A., Chapon, F., Milliez, P., Klug, D., Eymard, B., Duboc, D. :
Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1 Eur Heart J, 2017 ; (SP) :
Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1 Eur Heart J, 2017 ; (SP) :
Raess, M. A., Cowling, B. S., Bertazzi, D. L., Kretz, C., Rinaldi, B., Xuereb, J. M., Kessler, P., Romero, N. B., Payrastre, B., Friant, S., Laporte, J. :
Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy Hum Mol Genet, 2017 ; 26 (19) : 3736-3748
Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy Hum Mol Genet, 2017 ; 26 (19) : 3736-3748
Papadopoulos, C., Orlikowski, D., Prigent, H., Lacour, A., Tard, C., Furby, A., Praline, J., Sole, G., Hogrel, J. Y., De Antonio, M., Semplicini, C., Deibener-Kaminsky, J., Kaminsky, P., Eymard, B., Taouagh, N., Perniconi, B., Hamroun, D., Laforet, P. :
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme(R)) in 12 patients with advanced late-onset Pompe disease Mol Genet Metab, 2017 ; (SP) :
Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme(R)) in 12 patients with advanced late-onset Pompe disease Mol Genet Metab, 2017 ; (SP) :
Kishnani, P., Tarnopolsky, M., Roberts, M., Sivakumar, K., Dasouki, M., Dimachkie, M. M., Finanger, E., Goker-Alpan, O., Guter, K. A., Mozaffar, T., Pervaiz, M. A., Laforet, P., Levine, T., Adera, M., Lazauskas, R., Sitaraman, S., Khanna, R., Benjamin, E., Feng, J., Flanagan, J. J., Barth, J., Barlow, C., Lockhart, D. J., Valenzano, K. J., Boudes, P., Johnson, F. K., Byrne, B. :
Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid alpha-Glucosidase in Pompe Patients Co-administered with Alglucosidase alpha Mol Ther, 2017 ; 25 (5) : 1199-1208
Duvoglustat HCl Increases Systemic and Tissue Exposure of Active Acid alpha-Glucosidase in Pompe Patients Co-administered with Alglucosidase alpha Mol Ther, 2017 ; 25 (5) : 1199-1208
Lilleker, J. B., Rietveld, A., Pye, S. R., Mariampillai, K., Benveniste, O., Peeters, M. T., Miller, J. A., Hanna, M. G., Machado, P. M., Parton, M. J., Gheorghe, K. R., Badrising, U. A., Lundberg, I. E., Sacconi, S., Herbert, M. K., McHugh, N. J., Lecky, B. R., Brierley, C., Hilton-Jones, D., Lamb, J. A., Roberts, M. E., Cooper, R. G., Saris, C. G., Pruijn, G. J., Chinoy, H., van Engelen, B. G., all, Ukmyonet contributors :
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis Ann Rheum Dis, 2017 ; 76 (5) : 862-868
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis Ann Rheum Dis, 2017 ; 76 (5) : 862-868
Hachulla, E., Benveniste, O., Hachulla, E., Hamidou, M., Mouthon, L., Lozeron, P., Leger, J. M., Schleinitz, N., Vial, C., Viala, K. :
High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance Int J Neurosci, 2017 ; 127 (6) : 516-523
High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance Int J Neurosci, 2017 ; 127 (6) : 516-523
